BIO Official Bloggers Program: Focus on Biosimilars

Andrew Williams wrote a second part to his original blog entry on 2011 BIO International Convention preview… This time his focus is on Biosimilars:

For BIO attendees interested in learning more about the relatively new pathway for FDA approval of biosimilars, also known as follow-on biologics, there are several sessions devoted to the intricacies of the new law, or how the new legislation is impacting the BIO community.  The biosimilar framework was introduced last year in the Omnibus Health Care bill.  It is no surprise that biosimilars were a hot topic at the 2010 BIO International Convention, and it continues to garner much interest one year later at this year’s convention

Stay tune from more blog entries coming from the Patent Docs blog!

Events  |  Email This Post  |  Printer Friendly
Tags: , , , , ,

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>